| (2R)-N-Hydroxy-2-[(4-methoxyphenyl)sulfonyl-(pyridin-3-ylmethyl)amino]-3-methylbutanamide;hydrochloride | IC50 | 8.0 [1] |
| (2R)-N-Hydroxy-2-[(4-methoxyphenyl)sulfonyl-(pyridin-3-ylmethyl)amino]-3-methylbutanamide;hydrochloride | Ki | 1.27 [1] |
| 4-[4-(4-Chloro-phenoxy)-benzenesulfonylmethyl]-tetrahydro-pyran-4-carboxylic acid hydroxyamide | IC50 | 0.3 [1] |
| 4-[4-(4-Chloro-phenoxy)-benzenesulfonylmethyl]-tetrahydro-pyran-4-carboxylic acid hydroxyamide | Ki | 0.28 [1], 0.52 [2] |
| Marimastat | IC50 | 2.0 [1] |
| Prinomastat | IC50 | 0.2 [1], 0.4 [2], 0.5 [3], 1.5 [4] |
| Prinomastat | Ki | 0.04 [1] |
| Cipemastat | IC50 | 3.4 [1], 3.5 [2], 4.7 [3] |
| Cipemastat | Ki | 0.53 [1], 1.0 [2], 3.0 [3] |
| Pyrimidine-4,6-dicarboxylic acid bis-(4-fluoro-3-methyl-benzylamide) | IC50 | 8.0 [1] |
| Benzyl 6-Benzyl-5,7-Dioxo-6,7-Dihydro-5h-[1,3]thiazolo[3,2-C]pyrimidine-2-Carboxylate | IC50 | 23.0 [1], 30.0 [2], 51.0 [3] |
| Benzyl 6-Benzyl-5,7-Dioxo-6,7-Dihydro-5h-[1,3]thiazolo[3,2-C]pyrimidine-2-Carboxylate | Ki | 64.0 [1] |
| n-Hydroxy-2-[(4-methoxy-benzenesulfonyl)-pyridin-3-ylmethyl-amino]-3-methyl-benzamide | IC50 | 7.94 [1], 8.0 [2] |
| 2-[(4-Methylbenzyl)sulfanyl]-3,5,6,7-Tetrahydro-4h-Cyclopenta[d]pyrimidin-4-One | IC50 | 2400.0 [1] |
| 2-[(4-Methylbenzyl)sulfanyl]-3,5,6,7-Tetrahydro-4h-Cyclopenta[d]pyrimidin-4-One | Ki | 800.0 [1], 824.0 [2] |
| CID 6914621 | IC50 | 1417.0 [1] |
| CID 6914621 | Ki | 1417.0 [1] |
| 4-{[1-Methyl-2,4-Dioxo-6-(3-Phenylprop-1-Yn-1-Yl)-1,4-Dihydroquinazolin-3(2h)-Yl]methyl}benzoic Acid | IC50 | 0.67 [1], 14.0 [2] |
| 4-[(4-But-2-ynoxyphenyl)sulfonylmethyl]-N-hydroxy-1-propan-2-ylsulfonylpiperidine-4-carboxamide | IC50 | 157.0 [1], 230.0 [2] |
| N-({4'-[(1-Benzofuran-2-ylcarbonyl)amino]-1,1'-biphenyl-4-YL}sulfonyl)-L-valine | IC50 | 1.3 [1], 2.4 [2] |
| (2R,3R)-1-[4-[(2-Chloro-4-fluorophenyl)methoxy]phenyl]sulfonyl-N,3-dihydroxy-3-methylpiperidine-2-carboxamide | IC50 | 0.9 [1], 1.0 [2], 10.0 [3] |
| (2R)-2-[[4-(4-Methoxyphenyl)phenyl]sulfonylamino]-2-[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]acetic acid | IC50 | 0.4 [1], 0.5 [2], 11.0 [3] |
| 5-[3-Fluoro-4-[(4-oxo-3,5,6,7-tetrahydrocyclopenta[d]pyrimidin-2-yl)sulfanylmethyl]phenyl]-N-[(2S)-3-methyl-1-(methylamino)-1-oxobutan-2-yl]furan-2-carboxamide | IC50 | 2.7 [1], 8.1 [2] |
| 5-[3-Fluoro-4-[(4-oxo-3,5,6,7-tetrahydrocyclopenta[d]pyrimidin-2-yl)sulfanylmethyl]phenyl]-N-[(2S)-3-methyl-1-(methylamino)-1-oxobutan-2-yl]furan-2-carboxamide | Ki | 1.7 [1] |
| 4-[[[5-(2-Ethoxycarbonyl-1H-indol-5-yl)-1-methylpyrazole-3-carbonyl]amino]methyl]benzoic acid | IC50 | 1.0 [1], 4.0 [2], 11.0 [3], 31.0 [4] |
| (3S)-4-{[4-(But-2-ynyloxy)phenyl]sulfonyl}-N-hydroxy-2,2-dimethylthiomorpholine-3-carboxamide | IC50 | 2.4 [1], 3.0 [2] |
| 2-[(4-Chlorophenyl)methylthio]-1,5,6,7-tetrahydrocyclopenta[d]pyrimidin-4-one | IC50 | 3400.0 [1], 10300.0 [2] |
| 2-[(4-Chlorophenyl)methylthio]-1,5,6,7-tetrahydrocyclopenta[d]pyrimidin-4-one | Ki | 3800.0 [1] |
| CID 10370504 | IC50 | 73.0 [1] |
| 2-[(4-Methoxyphenyl)methylthio]-6-methyl-1H-pyrimidin-4-one | IC50 | 1600.0 [1], 4300.0 [2], 20000.0 [3] |
| 2-[(4-Phenylphenyl)sulfonylamino]pentanedioic acid | IC50 | 280.0 [1], 2100.0 [2], 13000.0 [3] |
| 3-(4-Hexyloxy-phenyl)-succinamic acid | IC50 | 1300.0 [1], 4800.0 [2], 27000.0 [3] |
| 2-(Biphenyl-4-ylsulfonamido)-N-hydroxyacetamide | IC50 | 2.4 [1], 2.8 [2] |
| 2-(Biphenyl-4-ylsulfonamido)-N-hydroxyacetamide | Ki | 2.0 [1] |
| N-Hydroxy-4-(4-phenylsulfanylphenyl)sulfonyl-1-prop-2-ynylpiperidine-4-carboxamide | IC50 | 0.4 [1], 1.0 [2] |
| (2S)-2-[[4-(4-Methoxyphenyl)phenyl]sulfonylamino]-3-methylbutanoic acid | IC50 | 6.0 [1], 24.2 [2] |
| N-(3-Methoxybenzyl)-4-Oxo-3,4-Dihydroquinazoline-2-Carboxamide | IC50 | 5.6 [1], 12.0 [2] |
| N-Hydroxy-2-[[4-(4-methoxyphenyl)phenyl]methyl]-1,1-dioxo-1,2-thiazolidine-3-carboxamide | Ki | 55.0 [1] |
| (2R,3R)-3-(Cyclopentylmethyl)-N-hydroxy-2-[[methyl(methylsulfonyl)amino]methyl]-4-oxo-4-piperidin-1-ylbutanamide | IC50 | 398.11 [1], 400.0 [2] |
| 4-((6-(4-Methoxybenzylcarbamoyl)-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)methyl)benzoic acid | IC50 | 6.72 [1], 30.5 [2] |
| 2-[Benzyl(4-methoxyphenylsulfonyl)amino]benzenecarbohydroximic acid | IC50 | 549.54 [1], 555.0 [2] |
| 2-[Benzyl(4-methoxyphenylsulfonyl)amino]-3-methoxybenzenecarbohydroximic acid | IC50 | 138.0 [1], 138.04 [2] |
| 2-[Methyl(4-methoxyphenylsulfonyl)amino]-3-methyl-5-bromobenzohydroximic acid | IC50 | 11.0 [1], 21.0 [2] |
| (2R)-2-[Benzyl-[4-(2-fluoroethoxy)phenyl]sulfonylamino]-N-hydroxy-3-methylbutanamide | IC50 | 11.0 [1] |
| 1-[4-(4-Chlorophenoxy)phenyl]-1,7,9-triazaspiro[4.5]decane-2,6,8,10-tetrone | Ki | 0.95 [1], 1.0 [2] |
| 2-[Methyl[4-(2-propynyloxy)phenylsulfonyl]amino]-3-methyl-5-bromobenzohydroximic acid | IC50 | 52.0 [1], 113.0 [2] |
| 2-(4'-Methoxy-4-biphenylylsulfonylamino)-5-phenyl-4-pentynoic acid | IC50 | 20.89 [1], 21.0 [2] |
| N-[(1S)-1-Cyclohexyl-2-(methylamino)-2-oxoethyl]-5-[3-fluoro-4-[(4-oxo-3,5,6,7-tetrahydrocyclopenta[d]pyrimidin-2-yl)sulfanylmethyl]phenyl]furan-2-carboxamide | IC50 | 4.4 [1], 6.3 [2], 7.9 [3] |
| (2R)-2-[[5-(4-Ethoxyphenyl)thiophen-2-yl]sulfonylamino]-2-(1-propan-2-yloxycarbonylpiperidin-4-yl)acetic acid | IC50 | 0.5 [1], 37.8 [2] |
| (2R)-2-[[5-(4-Ethoxyphenyl)thiophen-2-yl]sulfonylamino]-2-(1-propan-2-yloxycarbonylpiperidin-4-yl)acetic acid | Ki | 0.19 [1] |
| N-(2-Aminoethyl)-4-[4-[(4-oxo-3,5,6,7-tetrahydrocyclopenta[d]pyrimidin-2-yl)sulfanylmethyl]phenyl]benzenesulfonamide | IC50 | 3.4 [1], 8.3 [2] |
| N-(2-Aminoethyl)-4-[4-[(4-oxo-3,5,6,7-tetrahydrocyclopenta[d]pyrimidin-2-yl)sulfanylmethyl]phenyl]benzenesulfonamide | Ki | 13.5 [1] |
| Ilomastat | IC50 | 5.2 [1] |
| N-Isobutyl-N-[4-methoxyphenylsulfonyl]glycyl hydroxamic acid | IC50 | 3.0 [1] |
| N-Isobutyl-N-[4-methoxyphenylsulfonyl]glycyl hydroxamic acid | Ki | 3.1 [1] |
| (S)-2-(4'-Bromo-[1,1'-biphenyl]-4-ylsulfonamido)-3-methylbutanoic acid | IC50 | 8.0 [1] |
| N-Hydroxy-2-(N-isopropoxybiphenyl-4-ylsulfonamido)acetamide | IC50 | 25.0 [1] |
| N-Hydroxy-2-(N-isopropoxybiphenyl-4-ylsulfonamido)acetamide | Ki | 20.0 [1] |
| cis-2-Aminocyclohexylcarbamoylphosphonic acid | IC50 | 100000.0 [1] |
| (3R)-3-[[(2S)-1-[[(1S)-2-Methoxy-1-phenylethyl]amino]-3,3-dimethyl-1-oxobutan-2-yl]carbamoyl]-6-(3-methyl-4-phenylphenyl)hexanoic acid | IC50 | 2300.0 [1] |
| 4-[[(4-Oxo-1,5,6,7-tetrahydrocyclopenta[d]pyrimidin-2-yl)thio]methyl]benzoic acid methyl ester | IC50 | 2800.0 [1] |
| 4-[[(4-Oxo-1,5,6,7-tetrahydrocyclopenta[d]pyrimidin-2-yl)thio]methyl]benzoic acid methyl ester | Ki | 1526.0 [1] |
| (4S)-5-Amino-4-[[(2S)-2-[[(2S)-2-[[(4-bromophenyl)-hydroxyphosphoryl]methyl]-3-[3-[4-(3-chlorophenyl)phenyl]-1,2-oxazol-5-yl]propanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoic acid | Ki | 49.0 [1], 139.0 [2] |
| N-Hydroxy-1-(2-methoxyethyl)-4-[4-[4-(trifluoromethoxy)phenoxy]phenyl]sulfonylpiperidine-4-carboxamide | IC50 | 0.1 [1] |
| (3R,4R)-N-Hydroxy-4-[[4-[[2-(trifluoromethyl)benzimidazol-1-yl]methyl]benzoyl]amino]oxane-3-carboxamide | Ki | 10000.0 [1] |
| 4-Benzoyl-N-hydroxy-1-(4-methoxyphenylsulfonyl)piperazine-2-carboxamide | IC50 | 3.0 [1], 3.02 [2] |
| (2S)-2-[[4-(4-Fluorophenyl)phenyl]sulfonylamino]-3-methylbutanoic acid | IC50 | 43.0 [1] |
| (2S)-2-[[8-(Methoxycarbonylamino)dibenzofuran-3-yl]sulfonylamino]-3-methylbutanoic acid | IC50 | 120.0 [1] |
| 2-[4-[4-(Trifluoromethyl)phenoxy]piperidinosulfonyl]benzohydroximic acid | IC50 | 28.0 [1] |
| MMP-9/MMP-13 Inhibitor I | IC50 | 0.89 [1], 0.9 [2] |
| (4-Benzylphenyl)methyl-[2-[[(2S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl]carbamoyl]-4-phenylbutyl]phosphinic acid | IC50 | 14.0 [1], 21.0 [2] |
| 2-[Methyl[4-(2-butynyloxy)phenylsulfonyl]amino]-3-methyl-5-bromobenzohydroximic acid | IC50 | 154.0 [1] |
| N-Hydroxy-4-[(4-methoxyphenyl)sulfonyl-(pyridin-3-ylmethyl)amino]-8-phenylquinoline-3-carboxamide | IC50 | 4.0 [1] |
| (8S,11R,12S)-12-N-Hydroxy-8-N-(2-morpholin-4-yl-2-oxoethyl)-2,10-dioxo-11-[[4-[2-(trifluoromethyl)phenyl]phenyl]methyl]-1-oxa-3,9-diazacyclopentadecane-8,12-dicarboxamide | Ki | 653.0 [1] |
| 4-Acetyl-N-hydroxy-1-(4-methoxyphenylsulfonyl)piperazine-2-carboxamide | IC50 | 1.0 [1] |
| 4-(Furan-2-carbonyl)-N-hydroxy-1-(4-methoxyphenylsulfonyl)piperazine-2-carboxamide | IC50 | 2.5 [1], 2.51 [2] |
| 4-(Cyclohexanecarbonyl)-N-hydroxy-1-(4-methoxyphenylsulfonyl)piperazine-2-carboxamide | IC50 | 1.5 [1], 1.51 [2] |
| N-Hydroxy-1-(4-methoxyphenylsulfonyl)-4-(2-phenoxyacetyl)piperazine-2-carboxamide | IC50 | 2.1 [1], 2.19 [2] |
| N-Hydroxy-1-(4-methoxyphenylsulfonyl)-4-(thiophene-2-carbonyl)piperazine-2-carboxamide | IC50 | 1.9 [1], 1.91 [2] |
| N-Hydroxy-1-(4-methoxyphenyl)sulfonylpiperazine-2-carboxamide | IC50 | 1.7 [1] |
| N-Hydroxy-1-(4-methoxyphenyl)sulfonyl-4-(5-methyl-3-phenyl-1,2-oxazole-4-carbonyl)piperazine-2-carboxamide | IC50 | 26.92 [1], 27.0 [2] |
| ((4'-Chloro-[1,1'-biphenyl]-4-yl)sulfonyl)valine | IC50 | 48.0 [1] |
| 4-Hexanoyl-N-hydroxy-1-(4-methoxyphenylsulfonyl)piperazine-2-carboxamide | IC50 | 1.7 [1] |
| (2S)-2-[[4-[4-[(5-Bromo-4-methoxy-3-methyl-1-benzofuran-2-carbonyl)amino]phenyl]phenyl]sulfonylamino]-3-methylbutanoic acid | IC50 | 2.3 [1] |
| (2R,5R)-1-[4-[(2,4-Dichlorophenyl)methoxy]phenyl]sulfonyl-N,5-dihydroxy-3,3-dimethylpiperidine-2-carboxamide | IC50 | 3.0 [1], 10.0 [2] |
| 4-Benzoyl-N-hydroxy-1-(4-phenoxyphenylsulfonyl)-1,4-diazepane-2-carboxamide | IC50 | 1.29 [1], 1.3 [2] |
| (3S)-N-Hydroxy-4-(4-methoxyphenyl)sulfonyl-2,2-dimethyl-1,1-dioxo-1,4-thiazepane-3-carboxamide | IC50 | 2.1 [1] |
| 5-Methyl-5-(4-phenoxy-phenyl)-pyrimidine-2,4,6-trione | IC50 | 65.0 [1] |
| 5-Methyl-5-(4-phenoxy-phenyl)-pyrimidine-2,4,6-trione | Ki | 65.0 [1] |
| 2-[Benzyl(4-methoxyphenylsulfonyl)amino]-3-methylbenzenecarbohydroximic acid | IC50 | 50.0 [1], 50.12 [2] |
| N-Hydroxy-2-[2-methylpropyl-(4-phenylphenyl)sulfonylamino]acetamide | IC50 | 9.4 [1], 39.0 [2] |
| N,N'-Bis(pyridin-3-ylmethyl)pyrimidine-4,6-dicarboxamide | IC50 | 6600.0 [1] |
| (R)-N-Hydroxy-2-(4-methoxyphenylsulfonyl)-2-methyl-3-(4-(2-(piperidin-1-yl)ethoxy)phenyl)propanamide | IC50 | 1.0 [1] |
| N-[4-[2-(Hydroxyamino)-2-oxoethyl]oxan-4-yl]-4-[(2-methylquinolin-4-yl)methoxy]benzamide | Ki | 5025.0 [1] |
| 2-[4-[4-(Trifluoromethoxy)phenoxy]piperidinosulfonyl]benzohydroximic acid | IC50 | 33.0 [1] |
| 1-(4-Bromobenzyl)-N-hydroxy-4-(4-methoxyphenylsulfonyl)piperidine-4-carboxamide | IC50 | 2.0 [1] |
| 2-[Methyl[4-(2-butynyloxy)phenylsulfonyl]amino]acetohydroximic acid | IC50 | 99.0 [1] |
| 2-[Methyl[4-(2-butynyloxy)phenylsulfonyl]amino]acetohydroximic acid | Ki | 17.0 [1] |
| (S)-N-Hydroxy-4-(4-methoxyphenylsulfonyl)-2,2-dimethyl-1,4-thiazepane-3-carboxamide | IC50 | 0.9 [1] |
| N-Hydroxy-4-(4-methoxyphenyl)sulfonylthiomorpholine-3-carboxamide | IC50 | 1.0 [1] |